Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qiu-yue Ding
Observed name:
Qiuyue Ding
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0001-0002-3101
Observed ORCID:
0009-0001-0002-3101
OpenAlex ID:
A5011264472
HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma
2022
·
Fu-xue Huang
, Jun-wan Wu
, et al.
·
Frontiers in Immunology
·
21
Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma
2025
·
Linbin Chen
, Wanqian Liao
, et al.
·
Pharmaceuticals
·
10
PDF
Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal Melanoma
2026
·
Qiuyue Ding
, Junwan Wu
, et al.
·
Journal of Otolaryngology - Head and Neck Surgery
Show more works
View as search
Works count:
3
Citation count:
31
H-index:
2
I10-index:
2
Year
Topic
Type